Month: February 2017

Prexton News

Prexton Therapeutics Series B financing round raises €29 million

Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic.  Forbion & Seroba co-led the funding, forming an international consortium with Merck Ventures, Ysios and Sunstone.  Funding to finance two Phase II trials in Parkinson’s disease. Geneva, Switzerland and Amsterdam, The Netherlands, February 7, 2017 – Seroba’s new investee company, Prexton Therapeutics …

Prexton Therapeutics Series B financing round raises €29 million Read More »

Quanta Fluid News

Quanta Appoints World Leading Nephrologist to Medical Advisory Board

Seroba’s investee company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces it has appointed Dr Sandip Mitra to its Medical Advisory Board. Sandip is a practising Senior Consultant Nephrologist at Manchester Royal Infirmary where he leads one of the …

Quanta Appoints World Leading Nephrologist to Medical Advisory Board Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top